why choose us

First received: July 18, 2022

Clinical Trial: Effects of Immulina TM Supplements With PASC Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Post Acute COVID-19 Syndrome

Study Type: INTERVENTIONAL


Official Title: Effect of Immulina Supplements on Inflammatory Biomarkers Correlated With Clinical Symptoms in Patients With Long COVID (PASC)

Brief Summary: This is a multi-site study that will try to determine the effects of Immulina ™, a natural dietary supplement, on blood chemicals associated with inflammation that are often increased in patients with long COVID (also called PASC).

Read more